久久精品国产亚洲av高清漫画 ,麻豆果冻传媒新剧国产杜鹃,久久精品国产99久久香蕉

熱門搜索化學品最多只顯示前20條，請點擊“搜索化學品”查看所有結果

CAS登錄號

中文名

英文名

分子結構式

分子式

詳情

供應商

244092-76-0

Carbamic acid,[(1R)-1-(phenylmethyl)-2-propenyl]-, 1,1-dimethylethyl ester (9CI);
3R enantiomer

enantio-Oxytocin,1-(3-mercaptopropanoic acid)- (9CI);
enantio-Oxytocin,1-(3-mercaptopropionic acid)- (8CI);
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, enantio-oxytocin deriv.;
Deamino-D-oxytocin;
Deamino-enantio-oxytocin;
enantio-Oxytocin, deamino-

enantio-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl)

enantio-retro-Bradykinin(8CI,9CI);
enantio-Bradykinin,2-D-phenylalanine-4-D-serine-6-glycine-8-D-proline-;
D-Arginine,D-arginyl-D-phenylalanyl-D-prolyl-D-seryl-D-phenylalanylglycyl-D-prolyl-D-prolyl-;
D-Arginine,N2-[1-[1-[N-[N-[N-[1-(N-D-arginyl-D-phenylalanyl)-D-prolyl]-D-seryl]-D-phenylalanyl]glycyl]-D-prolyl]-D-prolyl]-

enantio-pseudo-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl);
Cyclo(D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl)

enantio-Sperm-activatingpeptide H 1 (Hemicentrotus pulcherrimus egg jelly coat) (9CI);
Glycine,N-[N-[N-[N-[N-[N-[N-[N-(N-glycyl-D-phenylalanyl)-D-a-aspartyl]-D-leucyl]-D-threonyl]glycyl]glycyl]glycyl]-D-valyl]-

enantio-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl)

enantio-Angiotensin II,5-D-valine- (8CI,9CI);
D-Phenylalanine,N-[1-[N-[N-[N-[N-(N2-D-a-aspartyl-D-arginyl)-D-valyl]-D-tyrosyl]-D-valyl]-D-histidyl]-D-prolyl]-

''Ironacetylchiral''

Iron, acetylcarbonyl(h5-2,4-cyclopentadien-1-yl)(triphenylphosphine)-,stereoisomer;
IRON ACETYL CHIRAL;
IRON ACETYL COMPLEX (-)-(R)-enantioMER;
IRON ACETYL COMPLEX (+)-(S)-enantioMER;
(R)-(-)-ACETYLCARBONYL(ETA5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON;
(R)-(-)-ACETYLCARBONYL((ETA)5-2,4-CYCLOPENTADIENE-1-YL)(TRIPHENYLPHOSPHINE)IRON;
(R)-(-)-ACETYLCYCLOPENTADIENYLIRONCARBONYLTRIPHENYLPHOSPHINE COMPLEX;
S(+)-CYCLOPENTADIENYL IRON ACETYL CARBONYL TRIPHENYLPHOSPHINE COMPLEX;
(S)-(+)-ACETYLCYCLOPENTADIENYLIRONCARBONYLTRIPHENYLPHOSPHINE COMPLEX

Iron, acetylcarbonyl(h5-2,4-cyclopentadien-1-yl)(triphenylphosphine)-,stereoisomer (9CI);
IRON ACETYL CHIRAL;
IRON ACETYL COMPLEX (-)-(R)-enantioMER;
IRON ACETYL COMPLEX (+)-(S)-enantioMER;
(R)-(-)-ACETYLCARBONYL(ETA5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON;
(R)-(-)-ACETYLCARBONYL((ETA)5-2,4-CYCLOPENTADIENE-1-YL)(TRIPHENYLPHOSPHINE)IRON;
(R)-(-)-ACETYLCYCLOPENTADIENYLIRONCARBONYLTRIPHENYLPHOSPHINE COMPLEX;
(S)-(+)-ACETYLARBONYL((ETA)5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON;
(S)-(+)-ACETYLCARBONYL(ETA5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON

Naphthalene,6-ethyldecahydro-1,6-dimethyl-2-(1-methylethyl)-1-propyl-, (1R,2R,4aR,6S,8aR)-;
Naphthalene,6-ethyldecahydro-1,6-dimethyl-2-(1-methylethyl)-1-propyl-, [1R-(1a,2b,4ab,6b,8aa)]-;
Naphthalene, 6b-ethyl-1,2,3,4,4ab,5,6,7,8,8aa-decahydro-2b-isopropyl-1b,6-dimethyl-1-propyl- (8CI);
3,4-Secoenantiopimarane

Naphthalene,decahydro-1,6,6-trimethyl-2-(1-methylethyl)-1-propyl-, (1R,2R,4aR,8aR)-;
Naphthalene,decahydro-1,6,6-trimethyl-2-(1-methylethyl)-1-propyl-, [1R-(1a,2b,4ab,8aa)]-;
3,4-Seco-16-norenantiopimarane

R-(+)-AMINOGLUTETHIMIDE TARTRATE SALT;
R(+)-P-AMINOGLUTETHIMIDE TARTRATE;
R-(+)-AMINOGLUTETHIMIDE TARTRATE SALT;
R-(+)-3-(4-AMINOPHENYL)-3-ETHYL-2,6-PIPERIDINEDIONE TARTRATE SALT;
R(+)-P-AMINOGLUTETHIMIDE TARTRATE ACTIVE enantioMER OF;
R-(+)-Aminoglutethimide L-Tartrate Salt

enantio-PAF (C16)

enantio-PAF (C16);
3-O-HEXADECYL-2-ACETYL-SN-GLYCERO-1-PHOSPHOCHOLINE;
3-O-HEXADECYL-2-O-ACETYL-SN-GLYCERO-1-PHOSPHOCHOLINE;
3-O-HEXADECYL-2-O-ACETYL-SN-GLYCERO-1-PHOSPHORYLCHOLINE;
D-ALPHA-PHOSPHATIDYLCHOLINE-BETA-ACETYL-GAMMA-O-HEXADECYL;
enantio-PLATELET ACTIVATING FACTOR (C16);
enantio-PAF (C16);
PAF (C16), enantio;
D-A-phosphatidylcholine

C26H54NO7P

詳情

供應商

毛片免费视频观看,久久亚洲国产精品123区,精品无人区麻豆乱码1区2区新区,久久久亚洲av成人网站,久久人人爽人人爽人人av东京热

化工產品